The FDA is considering a change to reduce how often warnings and health disclaimers appear on dietary supplement labels.
America is in the midst of a pharmacy crisis, and the Food and Drug Administration could make it much worse. Hundreds of ...
Libtayo's approval for high-risk cutaneous squamous cell carcinoma offers a new immunotherapy option, targeting PD-1 ...
The U.S. Food and Drug Administration (FDA) is weighing a change that could make warning labels on dietary supplements appear less often on packaging. Unlike prescription drugs, dietary supplements ...
The FDA is considering a rule change that would cut back on how often dietary supplement warnings must appear on packaging, a move experts say could make them easier to miss.
The FDA had earlier banned sale, distribution and use of certain brands of cough syrups after diethylene glycol, a toxic ...
New York has set new restrictions on the sale of kratom, an unregulated drug that’s been tied to at least 100 deaths in the ...
The U.S. Food and Drug Administration (FDA) approved six new therapies in December 2025 for blood cancers, prostate cancer, ...
The FDA issued a CRL for ONS-5010, citing the need for additional confirmatory efficacy evidence despite previous trials ...
The FDA issued a third complete response letter for ONS-5010/Lytenava, requesting confirmatory efficacy evidence for wet AMD treatment. Lytenava is an ophthalmic bevacizumab formulation, potentially ...
Botanic Tonics’ supplement drinks have taken convenience stores by storm—even as the company has battled allegations of ...
A black-box warning is not a neutral informational update. It is the FDA’s most aggressive regulatory communication via product labeling, intended to alert clinicians and patients to risks so grave ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback